Search papers, labs, and topics across Lattice.
This study introduces ILLUME+, a scalable post-hoc explainability framework designed to enhance cancer drug response predictions by moving beyond traditional univariate gene importance scores. By capturing multiple, complementary forms of explanation, ILLUME+ not only provides more stable gene importance assessments but also successfully recovers known drug-gene associations and mechanisms of action. The framework's integration into an end-to-end pipeline facilitates AI-assisted hypothesis generation, revealing novel interaction-driven molecular signals critical for advancing precision oncology.
ILLUME+ reveals that a multi-faceted approach to explainability can uncover hidden molecular interactions in cancer treatment, outperforming traditional methods.
Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights. Current explainability approaches in this setting are computationally costly, lack robustness, and reduce complex drug response to univariate gene importance scores, overlooking the coordinated gene activity that drives sensitivity and resistance. In this work, we present ILLUME+, a scalable post-hoc explainability framework that moves beyond single-gene assessments to capture multiple, complementary forms of explanation. Integrated into our end-to-end pipeline, ILLUME+ produces more stable gene importance scores than existing baselines, recovers established drug-gene associations and mechanisms of action, and enables AI-assisted hypothesis generation to uncover novel interaction-driven molecular signals in cancer biology.
